This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "telomere_attrition#Telomere-Initiated DNA Damage and Replicative Senescence"). Conforming nodes in disorder files should include the corresponding biological processes and causal edges, specialized to their disease context. This module is the aging-facing complement of the cancer-facing enabling_replicative_immortality module: this one models telomere ATTRITION driving senescence in normal/aging cells, whereas enabling_replicative_immortality models telomere-maintenance REACTIVATION that lets tumor cells escape that barrier. It also feeds cellular_senescence (telomere attrition is one of the senescence-inducing stresses). Key conformance target: "telomere_attrition#Telomere-Initiated DNA Damage and Replicative Senescence".
Is leukocyte telomere length reliable enough at the individual level to serve as anything more than a population-scale marker?
KNOWLEDGE GAP
OPEN
knowledge_gap_telomere_length_measurement_reliability
Attached to:
Leukocyte telomere length
Progressive Telomere Attrition
This gap is about measurement rather than biology, which makes it unusual among the aging-biomarker gaps and is why it is recorded separately. The association between short telomeres and mortality is established across 121,749 individuals. What is not established is whether a single measurement in one person means anything actionable. Three things work against it: assay technique contributes materially to between-study heterogeneity, interindividual variation is large relative to the age effect, and the mortality association attenuates in the oldest old, who are the population most trials would enrol. The 2025 Delphi consensus recommends the marker while giving it the lowest agreement of any on its list for precision and reliability, and notes that repeated measurement over a participant's lifetime may be required for meaningful inference. Resolving this is an assay-standardization problem before it is a biology problem.
Turquoise killifish telomere-length strain pair (Nothobranchius furzeri GRZ vs MZM-0403)
Naturally short-lived vertebrate aging model
Hartmann and colleagues measured telomere length, telomerase gene sequence, and telomerase activity across the two killifish strains that differ in lifespan. Age-dependent telomere shortening was present in the longer-lived strain and absent in the shorter-lived one, and Tert expression rose rather than fell in aged tissue. The model therefore reproduces telomere attrition itself in one strain while explicitly dissociating it from lifespan determination, which is the module's downstream claim.
Species
Turquoise killifish (Nothobranchius furzeri)
Background
Laboratory strain GRZ (approximately 3.5-month lifespan) compared against the wild-derived MZM-0403 strain (approximately 6-month lifespan), assayed in muscle and skin.
Pathograph links
Progressive Telomere Attrition
partially recapitulates
fidelity: moderate
Telomeres shorten measurably with age in muscle and skin of the MZM-0403 strain, reproducing the attrition node in a vertebrate whose entire lifespan fits in months. The short-lived GRZ strain does not show the same shortening, so the node is strain-conditional in this model.
Limitations: Attrition was detected in only one of the two strains studied, and the attrition that does occur proceeds despite rising Tert expression and high telomerase activity, unlike human somatic tissues where telomerase is largely silenced. Only muscle and skin were assayed. Rates of shortening in a teleost with active somatic telomerase should not be transferred to human replicative tissue without corroboration.
Readouts
Telomere length in muscle and skin
Telomere length in young versus old fish of both strains, measured by several independent methods.
Direction: DECREASED
Interpretation: Shortening in MZM-0403 is the direct structural correlate of the attrition node; its absence in GRZ is why the link is graded partial.
Evidence: 1
Tert expression in aged muscle and skin
Transcript levels of the telomerase reverse transcriptase gene Tert in aged versus young MZM-0403 tissue, with matched telomerase activity assays.
Direction: INCREASED
Interpretation: Telomeres shorten even as Tert rises, so attrition here is not simply a readout of failing telomerase, unlike the canonical human account.
Evidence: 1
Evidence: 1
Tissue Replenishment Failure and Age-Related Disease
fails to recapitulate
fidelity: low
The module places telomere attrition upstream of replicative exhaustion and shortened healthspan. In this model the causal arrow does not hold: the strain with the shortest lifespan is the one without telomere shortening, and the authors conclude its lifespan is not explained by telomere or telomerase status.
Limitations: This is a negative result about one species and two strains, not a general refutation of the module's downstream edge. Killifish retain somatic telomerase activity, so the ordinary human route from attrition to replicative senescence is not available for testing here, and the model's extremely compressed lifespan may simply end before attrition becomes limiting. It does establish that in this widely used aging model, lifespan differences must be attributed to something other than telomere dynamics.
Readouts
Lifespan difference between strains versus telomere and telomerase status
Maximum lifespan of the GRZ and MZM-0403 strains set against their telomere lengths, shortening rates, and telomerase activity.
Direction: UNCHANGED
Interpretation: The shorter-lived strain shows neither accelerated shortening nor reduced telomerase, so telomere status does not track lifespan in this model.
Evidence: 1
Evidence: 1
Curated as part of a tranche adding turquoise killifish models across the hallmarks-of-aging modules. The pairing matters: the same study that establishes killifish telomere attrition also rules it out as the cause of the strain lifespan difference, so citing this model for the module's upstream node does not license citing it for the downstream one.
Proctor-Kirkwood Telomere Shortening and Oxidative Stress Model
KINETIC
Mathematical model separating the contributions of the end-replication problem, oxidative stress, and a C-strand-specific exonuclease to the rate of telomeric DNA loss, and to the triggering of replicative senescence. Parameter variation is used to test which combinations of these mechanisms are compatible with the observed quantitative and qualitative features of telomere loss.
Pathograph links
Progressive Telomere Attrition
recapitulates
fidelity: moderate
Decomposes the per-division attrition rate into its replicative and oxidative components, so that the oxidative contribution can be varied independently.
The oxidative-stress term is the quantitative bridge from mitochondrial_dysfunction into this module - ROS accelerate attrition without any change in division rate.
Proctor2006 Telomere Uncapping Checkpoint Model
SBML
KINETIC
Stochastic model of how uncapped telomeres initiate the checkpoint pathway leading to cell-cycle arrest, built on the budding-yeast cdc13-1 system in which telomeres are left unprotected over a permissive temperature range. Encoded in SBML and simulated stochastically; captures generation of long single-stranded DNA regions and the dependence of the response on checkpoint proteins and nucleases.
Pathograph links
Telomere-Initiated DNA Damage and Replicative Senescence
partially recapitulates
fidelity: low
Models the step from an uncapped telomere to checkpoint activation and cell-cycle arrest, including the single-stranded DNA intermediate.
Limitations: Budding yeast carrying a temperature-sensitive cdc13-1 allele, so uncapping is acute and conditional rather than the gradual attrition-driven uncapping this node describes, and the arrest is reversible rather than a permanent mammalian senescence program.
The "Proctor2006" label follows the BioModels record name; the paper (PMID:17015293) appeared in J Cell Sci in 2007 after a 2006 epub.
Rastgou Talemi2015 DNA Damage Model with Persistent Telomere-Associated Foci
SBML
KINETIC
Extension of the two-lesion kinetic (TLK) model of double-strand-break repair that adds persistent telomere-associated DNA damage foci (TAF) as a distinct damage category. Competing model versions were subjected to formal model discrimination against extensive data; the selected parsimonious model recapitulates and predicts both transient and persistent DNA damage, supporting nonlinear dose-damage relationships and negligible repair saturation.
Pathograph links
Telomere-Initiated DNA Damage and Replicative Senescence
partially recapitulates
fidelity: moderate
Gives persistent telomere-associated damage its own kinetic compartment, distinguishing irreparable telomeric foci from repairable double-strand breaks.
Limitations: Calibrated on ionizing-radiation dose-response data for secondary cancer risk assessment, not on physiological replicative attrition; the persistence of TAF transfers, but the damage input does not.
Mathematical Modelling of Telomere Length Dynamics
KINETIC
Mathematical treatment of telomere length dynamics across a dividing cell population, addressing how the distribution of telomere lengths - not only the mean - evolves with successive divisions and governs the onset of replicative senescence.
Pathograph links
Progressive Telomere Attrition
recapitulates
fidelity: moderate
Treats attrition as a distribution over chromosome ends rather than a single average length, which is what determines when the shortest telomere triggers arrest.
Progressive Telomere Attrition
trigger
Because conventional DNA replication cannot fully copy the ends of linear chromosomes (the end-replication problem) and somatic telomerase is limiting, telomeres lose repeat sequence with each cell division and shorten progressively with age. This cumulative loss of telomeric DNA is the initiating lesion of the hallmark; age-related and premature-aging syndromes are characterized by short telomeres.
Downstream
-
Telomere-Initiated DNA Damage and Replicative Senescence
Show evidence (2 references)
"It has been proposed that the finite doubling capacity of normal mammalian cells is due to a loss of telomeric DNA and eventual deletion of essential sequences."
Establishes progressive loss of telomeric DNA with division as the basis of the finite replicative capacity of cells, the initiating attrition modeled here. Evidence source is IN_VITRO (human fibroblast study).
"Age-related diseases and premature ageing syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase."
States that age-related and premature-aging syndromes are characterized by short telomeres, supporting telomere attrition as the aging lesion (and contrasting the cancer telomerase-reactivation arm). Evidence source is OTHER because this is a review.
Telomere-Initiated DNA Damage and Replicative Senescence
central effector
When telomeres become critically short or uncapped they can no longer protect chromosome ends, which are then sensed as DNA double-strand breaks. The resulting persistent DNA-damage-response signaling enforces replicative senescence - an essentially permanent proliferative arrest. This is the conserved central effector that disease-specific telomere lesions converge upon, and the point at which telomere attrition feeds the cellular senescence module.
Downstream
-
Tissue Replenishment Failure and Age-Related Disease
Show evidence (2 references)
"This exhaustion of proliferative potential, called senescence, can be triggered when telomeres--the ends of linear chromosomes-cannot fulfil their normal protective functions."
Establishes that loss of telomere protective function triggers replicative senescence, the central effector modeled here. Evidence source is IN_VITRO (human fibroblast senescence study).
"Here we show that senescent human fibroblasts display molecular markers characteristic of cells bearing DNA double-strand breaks."
Shows that telomere-initiated senescent cells carry DNA double-strand-break damage markers, supporting the DNA-damage-response arm of this node. Evidence source is IN_VITRO (human fibroblast study).